Act, for' diphtheria antigens. This required them to contain-at least fifty' Lf. uni-ts per c.c.; a high level of potency which compelled more than half of the makers in England to withdraw their products, temporarily, from the market (Holt, 1950) . It was about this time, too, that Bousfield pointed out the necessity of an adequate first dose, at least 0.5 c.c. A.P.T., to give high and prolonged immunity, and also the enhancing effect on immunity of lengthening the time interval between doses of A.P.T. to at least four weeks. Since then diphtheria in England has been decreasing with increasing acceleration.
In Belfast, immunisation started in 1936. An extensive epidemic of diphtheria occurred in 1940 when only 15 per cent. of the child population had been immunisation. Dr. H. A. Warnock, then in charge of the immunisation scheme, was checking the effect of immunisation by Schick testing and by the incidence and severity of diphtheria in immunised children. By the end of 1940 he was convinced that the optimum first dose of A.P.T. was 0.5 c.c. From 1942, with increasing numbers of children immunised (now over 60 per cent.)', the incidence of diphtheria in Belfast has continuously declined. In the period 1942 to 1950 there has been sixty-one deaths from diphtheria, all in non-immunised children. In fact, since 1945 there has been an increasing case mortality rate in non-immunised children. Many of the fatal cases were infected with' the gravis strain of diphtheria bacillus.
The presence of this strain in Belfast has not resulted in-any increase in the incidence of diphtheria in the immunised.
While the advent of the gravis strain is usually an importation Professor J. W. McLeod of Leeds has postulated that it may arise by mutation from other strains of the diphtheria bacillus.
The striving after even better immunity has resulted in the production of a new antigen by Holt (Holt and Bousfield, 1949) called Purified Toxoid, Aluminium Phosphate precipitated (P.T.A.P.). This is a highly purified product in that practically all bacterial protein has been removed with the result that it very seldom causes local reactions. It has given even better Schick conversion rates than A.P.T., but it has been suggested that while it produces high antitoxic immunity it may not stimulate antibacterial immunity. This appears to be rather a fine point as the stimulation of bacterial antibodies can hardly be claimed for any diphtheria antigen all of which are essentially toxoids. P.T.A.P. has been used in the Belfast clinics for three years now, and children receiving it have not suffered any undue incidence of diphtheria when compared with their fellows who received A.P.T. over the same period.
Tetanus toxoid is in many respects a comparable antigen to diphtheria toxoid.
During the last war it not only practically eliminated deaths from tetanus but also the symptoms of tetanus in the actively immunised wounded. Here, apparently, the need for antibacterial immunity does not arise. The improved diphtheria toxoids should reach the same high efficiency by means of proper dosage and spacing of doses.
The present system of immunisation is to give the first two doses at 9 and 10 79 months of age followed by a booster dose at 5 years. This leaves a possibility of some waning of immunity at 3 or 4 years of age. This might be overcome by delaying the second dose until six or nine months after the first. This long interval would, however, result-in many second doses being overlooked.
SUMMARY. An association between inoculations and paralysis in poliomyelitis was not found in the 1950 epidemic in Belfast. The unusually high incidence of arm paralysis found elsewhere in inoculated children occurred in Belfast in non-inoculated children.
The use of a highly potent diphtheria antigen, such as P. 
